Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v3.19.3
Balance Sheet - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 4,494,540 $ 6,892,772
Deferred offering costs 529,203 344,936
Other current assets 84,878 80,247
Total current assets 5,108,621 7,317,955
Total assets 5,108,621 7,317,955
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 483,666 399,551
Total current liabilities 483,666 399,551
Total liabilities 483,666 399,551
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 9,291,421 shares issued and outstanding at September 30, 2019 and December 31, 2018 9,291 9,291
Additional paid-in capital 29,301,586 28,567,221
Accumulated deficit (24,673,727) (21,655,712)
Accumulated other comprehensive loss (12,195) (2,396)
Total stockholders' equity 4,624,955 6,918,404
Total liabilities and stockholders' equity $ 5,108,621 $ 7,317,955